Invitrogen™ Canine GM-CSF ELISA Kit

Ref.: BL-RE-093617Manufacturer ref.: EC5RBX10 10 x 96 tests
€4,995.00 excl. VAT

Canine GM-CSF quantitates canine GM-CSF in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant canine GM-CSF.

Accession number
facteur de stimulation de colonies 2 ; facteur de stimulation de colonies 2 (granulocyte-macrophage) ; facteur de stimulation de colonies ; LCR ; CSF2 ; Csfgm ; cytokine ; GMCSF ; Gm-CSF ; facteur stimulant les colonies de macrophages de granulocytes ; facteur stimulant les colonies de macrophages de granulocytes ; facteur stimulant les colonies de granulocytes-macrophages 2 ; facteur stimulant les colonies de granulocytes-macrophages ; MGC131935 ; MGC138897 ; MGC151255 ; MGC151257 ; MGI-IGM ; M-GM-CSF ; Molgramostim ; put. GM-CSF ; sargramostime
Dose range
0.13 to 25 ng/ml
Sensitivity of the dosage
0.13 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Canine GM-CSF quantitates canine GM-CSF in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant canine GM-CSF.

Canine GM-CSF quantitates canine GM-CSF in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant canine GM-CSF.

GM-CSF (stimulating factor for granulocyte-macrophage colonies) is a hematopoietic growth factor of 14.6 kDa that exists in both glycosylated and non-glycosylated bioactive form, and stimulates the development of granulocytes, macrophages, early megacaryocytes, and progenitor cells of eosinophiles. The active form of the GM-CSF protein is extracellularly found as homodimer and the GM-CSF gene was located in a group of genes related to the chromosome region 5q31, which is known to be associated with interstitial suppressions in 5q syndrome and acute myeloid leukemia. Other genes in the group include those coding interleukins 4, 5 and 13. The ability of recombinant GM-CSF to increase the recovery of haematopoietic cells has become an area of concentration in the therapeutic treatment of patients following bone marrow transplantation. Recent studies of GM-CSF have been conducted in inflammatory and autoimmune diseases such as arthritis, arthritis-related interstitial lung diseases, nephritis and psoriasis. In CNS, depletion or neutralization of GM-CSF was studied for experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS).

Sensitivity

Sensitivity of dosage: 0.13 ng/ml.

Measurement range

Dose range: 0.13 to 25 ng/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Reproducibility

Coefficient of intradose variation < 10%, interdose < 12%.

Target

Target: GM-CSF.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17864040
Specifications
Accession numbercolony stimulation factor 2 ; colony stimulation factor 2 (granulocyte-macrophagus); colony stimulation factor LCR; CSF2; Csfgm; cytokine; GMCSF; Gm-CSF ; stimulating factor in granulocyte macrophages colonies ; stimulating factor in macrophage colonies d
Dose range0.13 to 25 ng/ml
Sensitivity of the dosage0.13 ng/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)P48749
Gene symbol(s)CSF2
Coefficient of inter-dose variation< 12%
Coefficient of intra-dose variation< 10%
Contents of kits96-well pre-coated plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity10 x 96 tests
Regulatory statusUse exclusively for research
TargetGM-CSF
Test time1 h 20 min
Physical characteristics
Volume of sampleSerum, 50 μl; Plasma, 50 μl; Supernatant, 50 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EC5RBX10
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.